This Article Full Text Full Text (PDF) All Versions of this Article: 93/3/1013    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Yamamoto, M. Articles by Sugimoto, T. PubMed PubMed Citation Articles by Yamamoto, M. Articles by Sugimoto, T. Related Collections Calcium and Bone Metabolism Diabetes and Insulin Female Endocrinology

Serum Pentosidine Levels Are Positively Associated with the Presence of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes

Internal Medicine 1, Shimane University Faculty of Medicine, Shimane 693-8501, Japan

Address all correspondence and requests for reprints to: Masahiro Yamamoto, M.D., Ph.D., Internal Medicine 1, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane, 693-8501, Japan. E-mail: masa-ya{at}med.shimae-u.ac.jp; yamaguch{at}med.shimane-u.ac.jp; yamauchi{at}med.shimane-u.ac.jp; syano{at}med.shimane-u.ac.jp; or sugimoto{at}med.shimane-u.ac.jp.

Context: Although type 2 diabetic patients are at increased risk of fractures, bone mineral density (BMD) may not be useful for assessing the risk. Recent studies have reported that increased bone content of pentosidine (PEN) is associated with its plasma concentration and bone fragility.

Objective and Methods: To examine the association between serum PEN levels and vertebral fractures (VFs) in Japanese type 2 diabetic patients (77 males older than 50 yr and 76 postmenopausal females), we compared parameters including BMD, PEN, serum bone-specific alkaline phosphatase, and urinary levels of N-telopeptide between those with and without VFs.

Results: Comparison of diabetic subjects with and without VFs revealed no significant differences in BMD values or bone metabolic markers in either gender. In contrast, PEN levels in women with VFs were significantly higher than in those without VFs (0.0440 ± 0.0136 vs. 0.0321 ± 0.0118 µg/ml; P < 0.001). Multivariate logistic regression analysis adjusted for age, height, weight, hemoglobin A1c, estimated glomerular filtration rate, the presence of diabetic complications, histories of taking insulin or pioglitazone, risk factors for osteoporosis, and lumbar BMD identified PEN levels as a factor associated with the presence of VFs in postmenopausal diabetic women independent of BMD, risk factors for osteoporosis, diabetic status, and renal function (odds ratio 2.50, 95% confidential interval 1.09–5.73 per SD increase; P = 0.0302).

Conclusion: PEN levels, but not BMD, may be useful for assessing the risk of prevalent VFs in postmenopausal diabetic women and may reflect bone quality in this group.